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ABSTRACT
Interleukin (IL)-1β is associated with hypotension and cardiovascular
collapse inmammals during heat stroke, and themRNAexpression of
this pro-inflammatory cytokine increases dramatically in the blood of
Atlantic cod (Gadus morhua) at high temperatures. These data
suggest that release of IL-1β at high temperatures negatively impacts
fish cardiovascular function and could be a primary determinant
of upper thermal tolerance in this taxa. Thus, we measured the
concentration-dependent response of isolated steelhead trout
(Oncorhynchus mykiss) coronary microvessels (<150 μm in
diameter) to recombinant (r) IL-1β at two temperatures (10 and
20°C). Recombinant IL-1β induced a concentration-dependent
vasodilation with vessel diameter increasing by approximately 8
and 30% at 10−8 and 10−7 mol l−1, respectively. However, this effect
was not temperature dependent. Both vessel denudation and
cyclooxygenase blockade (by indomethacin), but not the nitric
oxide (NO) antagonist L-NIO, inhibited the vasodilator effect of rIL-
1β. In contrast, the concentration-dependent dilation caused by the
endothelium-dependent calcium ionophore A23187 was completely
abolished by L-NIO and indomethacin, suggesting that both NO and
prostaglandin signaling mechanisms exist in the trout coronary
microvasculature. These data: (1) are the first to demonstrate a
functional link between the immune and cardiovascular systems in
fishes; (2) suggest that IL-1β release at high temperatures may
reduce systemic vascular resistance, and thus, the capacity of fish to
maintain blood pressure; and (3) provide evidence that both NO and
prostaglandins play a role in regulating coronary vascular tone, and
thus, blood flow.
KEY WORDS: Vasomotor responses, Oncorhynchus mykiss, Heart,
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INTRODUCTION
Interleukin (IL)-1β is a pro-inflammatory cytokine that has a
number of localized and systemic biological effects, and is essential
to the initiation and regulation of immune and inflammatory
responses in mammals (Dinarello, 1997). However, not all of its
biological and physiological effects appear to be immune or
inflammation related. Increases in plasma IL-1β levels are
associated with hypotension and cardiovascular collapse in
mammals during heat stroke (Chiu et al., 1995; Lin et al., 1997;
Leon, 2006), a phenomenon that can be mimicked by IL-1β
injection and eliminated by pre-treatment with IL-1β receptor
antagonists (Chiu et al., 1995; Lin et al., 1997). IL-1β induces
vasodilation of porcine cerebral arterioles (Shibata et al., 1996) and
canine basilar arteries (Osuka et al., 1997). Finally, IL-1β alters the
excitation–contraction coupling characteristics of cardiomyocytes
(Combes et al., 2002; Radin et al., 2008), including calcium
regulation and cycling (Duncan et al., 2010), and thus reduces
cardiomyocyte contractility (Combes et al., 2002; Duncan et al.,
2010).
While it is clear that IL-1β can significantly affect mammalian
cardiac function and vascular resistance (Bataillard and Sassard,
1994; Graff and Gozal, 1999; Maher et al., 2003 and above
references), the mechanism(s) that modulates the effects of IL-1β on
the vasculature is not well understood. There is evidence that IL-1β
induces the production and/or release of vasoactive substances such
as prostaglandins (PGs) and nitric oxide (NO) from mammalian
vascular cells (Rossi et al., 1985; Hirafuji et al., 2002; Proescholdt
et al., 2002; Schiltz and Sawchenko, 2002; Jedrzejowska-Szypulka
et al., 2009). However, the results of experiments investigating the
role of these two biological agents in modulating vascular resistance
have been quite variable. For example, IL-1β induces inducible
nitric oxide synthase (iNOS) gene expression and de novo synthesis
in rat vascular endothelial cells and cardiomyocytes (Kanno et al.,
1994; Tsujino et al., 1994). However, in the canine basilar artery
(McKean et al., 1994), human vascular smooth muscle cells
(Beasley and McGuiggin, 1995) and isolated rabbit mesenteric
arteries (Marceau et al., 1991), IL-1β induces the release of
cyclooxygenase 2 (COX-2), a key enzyme in the catalytic
conversion of arachidonic acid to PGs, but not NO. Furthermore,
a positive-feedback mechanism has been suggested for human
endothelial and vascular smooth muscle (VSM) cells (Warner et al.,
1987a,b; Proescholdt et al., 2002), where IL-1β stimulates the
synthesis of more IL-1β, and induces the production and release of
other vasoactive agents such as endothelin-1 (Jedrzejowska-Szypulka
et al., 2009) and serotonin (Chiu et al., 1995).
Interestingly, the mRNA expression of this cytokine increases
dramatically (by ∼25-fold) in the blood of Atlantic cod (Gadus
morhua) when water temperature is gradually increased to 19°C
(Pérez-Casanova et al., 2008). A significant increase in IL-1β
expression is seen in LPS (bacterial lipopolysaccharide)-infected
trout exposed to an increase in water temperature (i.e. to stimulate
behavioral fever) when compared with trout kept at control
temperature (Gräns et al., 2012). Finally, systemic vascular
resistance falls in rainbow trout at elevated temperatures (>18°C)
(Gamperl et al., 2011). These findings suggest that in fish, as in
mammals, this cytokine plays an important role in the loss of
cardiovascular function observed at high temperatures (Farrell et al.,Received 9 January 2015; Accepted 12 May 2015
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1996, 2009; Farrell, 2009; Gollock et al., 2006; Gamperl et al.,
2011) and has direct effects on the microvasculature. Changes in
tissue perfusion or vascular resistance are primarily mediated by the
dilation or constriction of small arteries and arterioles (<150 µm in
diameter) (Duling et al., 1981; Kuo et al., 1988; Berne and Levy,
1997). Therefore, the main goals of this study were to use
recombinant trout IL-1β (rIL-1β) to: (1) determine whether this
cytokine has vasoactive effects on steelhead trout (Oncorhynchus
mykiss) isolated coronary microvessels, and if so, whether these
effects are temperature dependent; and (2) examine the potential
roles of the endothelium, NO and PGs in IL-1β-induced changes in
isolated coronary microvessel tone. This rIL-1β has been shown to
be strongly bioactive both in vitro (Hong et al., 2001; Peddie et al.,
2001, 2002) and in vivo (Holland et al., 2002; Hong et al., 2003).
In addition, because of the controversy surrounding the
involvement of NO and PGs as endothelial-derived relaxation
factors (EDRFs) in fish (see Olson and Villa, 1991; Kågström and
Holmgren, 1997; Park et al., 2000; Jennings et al., 2004), we
decided to investigate the possible role played by these two
vasoactive agents in the concentration-dependent vasodilation
induced by the endothelium-dependent calcium ionophore
A23187. Several studies have indicated that A23187 is an
endothelium-dependent vasodilator of fish vessels (Olson and
Villa, 1991; Park et al., 2000; Jennings et al., 2004).
RESULTS
The average resting internal diameter (ID) of isolated coronary
arterioles from steelhead trout (Oncorhynchus mykiss Walbaum
1792) used in this study (N=50) was 83.6±3.0 µm, which was 68%
of maximal vessel diameter (123.0±2.2 µm).
Vasoactivity of recombinant IL-1β
At 10°C, rIL-1β caused a concentration-dependent dilation of
isolated coronary microvessels, with increases in vessel diameter
of approximately 4, 10 and 31% at 10−9, 10−8 and 10−7 mol l−1,
respectively (Fig. 1). Vessels at 20°C also showed concentration-
dependent dilation to rIL-1β. While the response at 20°C appeared
to be somewhat blunted (no difference compared with the sham
injection control at 10−9 mol l−1 and a maximal dilation of only
22% at 10−7 mol l−1), the degree of dilation at 10−8 and 10−7 mol l−1
rIL-1βwas not significantly different between temperatures (Fig. 1).
Effectiveness of endothelial denudation
Based on a number of criteria, endothelial denudation of isolated
coronary microvessels using the non-ionic detergent 3-[(3-
cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS,
0.4%) was a success. An intact endothelium was clearly visible in
control vessels (Fig. 2A), whereas these cells were merely vestigial
in vessels treated with CHAPS (Fig. 2B). The concentration-
dependent dilation observed in intact isolated coronary microvessels
with 10−9 to 10−4 mol l−1 of the endothelium-dependent calcium
ionophore A23187 (maximum dilation, 24.6±6.2%) was abolished
after treatment with CHAPS. Finally, direct stimulation of the
smooth muscle in denuded vessels with the NO donor sodium
nitroprusside (SNP, 10−4 mol l−1) elicited a significant (18.3±9.0%)
vasodilator response (Fig. 2C). This latter result indicated that
smooth muscle function was intact following denudation.
Role of the endothelium, NO and prostaglandins in rIL-1β-
induced dilation
Endothelial denudation of trout coronary microvessels using CHAPS
(0.4%) completely abolished the rIL-1β-induced vasodilation
(Fig. 3A). The non-selective NO synthase inhibitor N5-(1-
iminoethyl)-L-ornithine, dihydrochloride (L-NIO, 10−4 mol l−1) had
no effect on the vasodilator response of isolated trout coronary
microvessels to increasing concentrations of rIL-1β (Fig. 3B). In
contrast, pre-incubation with the non-selective cyclooxygenase
(COX) inhibitor indomethacin (INDO, 10−4 mol l−1) greatly
reduced the vasodilator effect caused by 10−7 mol l−1 rIL-1β (i.e.
from approx. 18.5 to 4% of resting ID) (Fig. 3C).
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Fig. 1. Vasomotor responses of trout coronary microvessels to
increasing concentrations of recombinant interleukin-1β at two
experimental temperatures. Vessels tested at 20°C were acutely warmed
(over 1 h) from 10°C and then allowed to acclimate to 20°C (∼30 min) before
rIL-1β injections were initiated. Dissimilar lower case letters indicate significant
differences in the response to the various concentrations of rIL-1β in vessels
tested at 10°C, whereas dissimilar capital letters indicate differences in the
response to rIL-1β in vessels tested at 20°C. Significant differences between
vessels exposed to rIL-1β (10 or 20°C) vs sham injections (at 10°C), at a
particular concentration of rIL-1β, are indicated by *P<0.05 and ‡0.1>P≥0.05.
Experimental temperature had no effects on vessel responses to rIL-1β. Note
that the series of sham injections (i.e. saline with 0.2 mmol l−1 DTT) did not
result in noticeable (i.e. ≤1%) changes in vessel ID. Thus, we considered any
change in vessel ID greater than ∼3% (mean change plus 2 s.d. caused by the
sham injection) to be biologically significant. All concentrations are in mol l−1.
List of abbreviations
ANOVA analysis of variance
CHAPS 3-[(3-cholamidopropyl) dimethylammonio]-1-
propanesulfonate, ionic detergent
COX cyclooxygenase
DTT dithiothreitol
EDRF endothelium-derived relaxing factor
eNOS endothelial nitric oxide synthase
ID internal diameter
IL interleukin
INDO indomethacin, non-selective cyclooxygenase
inhibitor
iNOS inducible nitric oxide synthase
L-NIO N5-(1-iminoethyl)-L-ornithine, dihydrochloride,
NO synthase inhibitor
LPS bacterial lipopolysaccharide
nNOS neurally derived nitric oxide synthase
NO nitric oxide
NOS nitric oxide synthase
PG prostaglandin
rIL-1β recombinant interleukin-1β
SNP sodium nitroprusside
TEM transmission electron microscopy
VSM vascular smooth muscle
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Role ofNOandPGs in thecalcium ionophoreA23187 induced
dilation
Pre-incubation of trout coronary microvessels with L-NIO (10−4
mol l−1) or INDO (10−4 mol l−1) completely abolished the
vasodilator effect of A23187, and instead, resulted in a significant
concentration-dependent vasoconstriction. This constriction with
10−7 to 10−4 mol l−1 A23187 ranged from 3.5 to 16% of resting ID
for L-NIO-exposed vessels and from 4 to 9% of resting ID for those
incubated with INDO (Fig. 4).
DISCUSSION
Vasoactivityof recombinant IL-1βandtheeffectof temperature
This is the first study where the vasoactivity of trout (fish) rIL-1β
has been investigated and we show that this cytokine caused a
20–30% dilation of isolated coronary microvessels that was
independent of experimental temperature (10 vs 20°C) (Fig. 1).
The magnitude of rIL-1β-induced vasodilation in trout coronary
microvessels is consistent with what has been reported for
mammalian vessels acutely exposed to this cytokine. IL-1β
increased cerebral pial arteriolar diameter in a concentration-
dependent manner in piglets, reaching a maximum dilation of
approximately 19% from baseline (Shibata et al., 1996) and dilated
the cerebral basilar artery in anaesthetized dogs by approximately
30% (Osuka et al., 1997). However, it is unclear what the effect of
long-term exposure to this cytokine would have on trout coronary
tone and blood flow. Long-term treatment with IL-1β induced
vasospastic responses in the coronary vessels of pigs (Shimokawa
et al., 1996) and there is a growing body of evidence that links IL-1β
with reduced cerebral blood flow in mammals (Proescholdt et al.,
2002; Maher et al., 2003; Jedrzejowska-Szypulka et al., 2009). This
dependence of the vasoactive effects of IL-1β on time of exposure
is not surprising given the broad spectrum of activities of this
cytokine, and that many of its downstream actions occur over a
prolonged period and involve other vasoactive substances such as
IL-6 and endothelin-1 (Maher et al., 2003; Jedrzejowska-Szypulka
et al., 2009).
In this study, we show that temperature (10 vs 20°C) did not have
a significant effect on the dose-dependent response of trout
coronary microvessels to rIL-1β (Fig. 1). Nonetheless, the lack of
a temperature effect on the dilator response of trout isolated
coronary microvessels does not preclude the possibility that the
impacts of this cytokine on vasoactivity and blood flow are
temperature dependent. The absence of a temperature effect on rIL-
1β-induced coronary microvessel dilation could be related to the fact
that dissection was performed at 4°C, prior to experiments at 10°C
and 20°C. Amelio et al. (2013) showed that acute temperature
changes abolished nitric-oxide-dependent modulation of the eel
(Anguilla anguilla) heart’s Frank–Starling mechanisms. Further, it
is possible that 1 h of exposure to 20°C was not long enough to
allow for sufficient physiological changes to occur that impact
microvessel tone. An increase in IL-1β receptor density could
increase the strength of the response of the vessels to rIL-1β, and
Helwig and Leon (2011) report that while protein expression of
soluble IL-1 subtype-1 receptor in the plasma of mice does not
change immediately upon exposure to hyperthermia, it is
significantly elevated after 24 h. Second, there is growing
evidence that temperature can influence the expression of IL-1β
mRNA in fish. In Atlantic cod, a gradual increase in water
temperature (from 10 to 20°C; 1°C every 5 days) resulted in a 25-
fold increase in plasma IL-1β mRNA expression (Pérez-Casanova
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A B Fig. 2. Trout coronary microvessel structure before and
after endothelial denudation, and vasomotor responses
to increasing concentrations of the calcium ionophore
A23187. Denuded vessels were exposed to CHAPS (0.4%)
by intraluminal injection (0.3 ml) for approximately 2 min.
Intact endothelial cells are visible on the luminal surface of
the control vessel (A), while in the treated vessel the
endothelial cell layer is visibly reduced (B). See Materials
and methods for details on TEM methodology.
(C) Vasomotor responses of trout coronary microvessels
to increasing concentrations of A23187. SNP (sodium
nitroprusside, 10−4 mol l−1) was administered at the end of
each trial to test for vascular smooth muscle viability in the
denuded vessels. ‡ indicates a significant difference
between denuded microvessels after exposure to 10−4 mol
l−1 of A23187 versus SNP injection. Dissimilar letters
indicate significant differences between concentrations of
A23187, *P<0.05 between control (intact) and denuded
vessels at a particular concentration of A23187. Note that
the series of sham injections (saline containing ethanol) did
not result in any noticeable (i.e. ≤0.5%) changes in vessel
ID. Thus, we considered any change in vessel ID greater
than 2% (mean change plus 2 s.d. caused by sham
injection) to be biologically significant. All concentrations are
in mol l−1.
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et al., 2008). Trout injected with bacterial lipopolysaccharide show a
significant increase in head kidney IL-1β transcript expression if
subjected to a temperature increase from 13.5 to 16°C (Gräns et al.,
2012). Finally, cultured trout head kidney leukocytes transferred to
22°C at the time of LPS exposure showed a 64% increase in IL-1β
mRNA expression relative to cells kept at 14°C (Zou et al., 2000).
Thus, while our results show that the concentration-dependent
response of trout coronary microvessels to rIL-1β is not affected by
exposure to acute high temperatures (20°C), it is very likely that the
effects of IL-1βwill be enhanced at high temperatures because of an
increase in concentration of this cytokine.
Future studies should explore the effects of rIL-1β administration
on isolated vessels and isolated cell cultures (e.g. endothelial and
VSM cells) exposed to elevated temperatures for longer periods, but
also from fish acclimated to high temperatures for various periods of
time. Identifying the location of IL-1 receptors along the trout
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Fig. 3. Effect of vessel denudation, L-NIO and indomethacin on trout
coronary microvessel dilation in response to recombinant interleukin-1β.
(A) Vessel denudation was achieved by exposing the intraluminal surface of the
vessel to the non-ionic detergent CHAPS (0.4%). Vessels were incubated for
30 minwitheither theNOS inhibitor L-NIO (10−4 mol l−1) (B), or theCOX inhibitor
INDO (10−4 mol l−1) (C), before rIL-1β injectionswere initiated. Dissimilar capital
letters indicate significant (P<0.05) differences in the response to the various
concentrations of rIL-1β in control (intact) vessels, while dissimilar lower case
letters indicate differences in the response to rIL-1β in vessels incubated with
either L-NIO (B) or INDO(C).Significant differencesbetweencontrol (intact) and
denuded vessels are indicated by *, while ** indicates a significant difference
between vessels in the presence (open circles) versus absence (filled circles) of
blocker (i.e. L-NIO or INDO) at a particular concentration of rIL-1β (P<0.05,
except where indicated ‡, where 0.1>P≥0.05). Sodium nitroprusside (SNP,
10−4 mol l−1)wasadministered at theendof each trial to test for vascular smooth
muscle viability in denuded vessels, and § indicates a significant difference
between denuded microvessels after exposure to 10−7 mol l−1 rIL-1β (with or
without blocker) versus after SNP injection. Note that a series of sham (saline
containing DTT) injections did not result in any noticeable (i.e. ≤1%) change in
vessel ID. Thus, we considered any change in vessel ID greater than 3% (mean
change plus 2 s.d. caused by the sham saline injections) to be biologically
significant. All concentrations are in mol l−1.
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Fig. 4. Effect of L-NIO and indomethacin on trout coronary microvessel
dilation induced by the calcium ionophore A23187. Vessel denudation was
achieved by exposing the intraluminal surface of the vessel to the non-ionic
detergent CHAPS (0.4%). Vessels were incubated for 30 min with either the
NOS inhibitor L-NIO (10−4 mol l−1) (A) or the COX inhibitor INDO (10−4 mol l−1)
(B), before A23187 injections were initiated. Dissimilar capital letters indicate
significant (P<0.05) differences in the response to the various concentrations
of A23187 in control (intact) vessels, while dissimilar lower case letters indicate
differences in the response to A23187 in vessels incubated with either L-NIO
(A) or INDO (B). To improve clarity of the figure, letters are not included where
differences were not significant. Significant differences between control (intact)
and denuded vessels are indicated by *, while ** indicates significant
differences between vessels in the presence (open circles) versus absence
(filled circles) of blocker (i.e. L-NIO or INDO) at a particular concentration of
A23187 (P<0.05). Sodium nitroprusside (SNP, 10−4 mol l−1) was administered
at the end of each trial to test for vascular smooth muscle viability in denuded
vessels, and § indicates a significant difference between denuded
microvessels after exposure to 10−4 mol l−1 A23187 versus after SNP injection.
Note that a series of sham saline (containing ethanol) injections did not result in
a noticeable (i.e. ≤0.5%) change in vessel ID. Thus, we considered any
change in vessel ID greater than 2% (the mean change plus 2 s.d. caused by
the sham saline injections) to be biologically significant. All concentrations are
in mol l−1.
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coronary vasculature (i.e. by immunohistochemistry techniques),
ascertaining the influence of acclimation temperature on the density
of these receptors, as well as determining in vivo plasma IL-1β
protein levels under different thermal challenges will also be key to
understanding the role of this cytokine in regulating vascular
resistance.
Role of the endothelium, NO and prostaglandins in
rIL-1β-induced dilation
From our results, it is apparent that rIL-1β-induced dilation of trout
coronary vessels is endothelium dependent (e.g. see Fig. 2), and
largely mediated by prostaglandins because INDO, but not L-NIO,
decreased the vasodilator effect of this cytokine (Fig. 3). The
involvement of PGs in IL-1β-mediated responses has been
previously reported in fish. Hong et al. (2001, 2003) showed that
while neither IL-1β nor COX-2 were constitutively expressed in
rainbow trout, the expression of COX-2 mRNA increased after
stimulation of both head kidney and macrophage cell lines with rIL-
1β. Further, increased COX-2 transcript levels have been reported in
the head kidney after in vivo exposure (intraperitoneal injection) of
both trout (Hong et al., 2003) and sea bass (Dicentrarchus labrax)
(Buonocore et al., 2005) to rIL-1β.
Role of NO and prostaglandins in calcium ionophore A23187-
induced dilation
The existence of an endothelial NO system in the fish vasculature
has been debated for a number of years, in large part because
molecular approaches (i.e. molecular cloning and bioinformatic
analysis of genomes) have not been able to identify an eNOS
isoform (i.e. NOS3) in fish, only the nNOS (i.e. NOS1) and iNOS
(i.e. NOS2) isoforms (Lepiller et al., 2009; Olson and Donald, 2009;
González-Domenech andMuñoz-Chápuli, 2010; Fago et al., 2012).
However: (1) a number of authors show that fish vascular beds are
dilated by NO, and thus, provide evidence for an endothelial NO
system in this taxa (Mustafa et al., 1997; Nilsson and Söderström,
1997; Mustafa and Agnisola, 1998); (2) several studies (Fritsche
et al., 2000; McNeill and Perry, 2006; Wang et al., 2007; Amelio
et al., 2008) have identified eNOS immunoreactivity in various fish
tissues, including the vascular endothelium, when using
heterologous mammalian eNOS antibodies (Olson and Donald,
2009; Imbrogno et al., 2014); and (3) Andreakis et al. (2011)
suggest that a neuronal NOS (nNOS) isoform with an ‘endothelial-
like’ consensus may cover some functional features typical of the
eNOS isoform. As has previously been reported for mammals
(Taniguchi et al., 1999; Oliveira et al., 2009), we showed that NO is
involved in A23187-mediated vasodilation of isolated trout
coronary arterioles (Fig. 4A), and that this effect was completely
dependent on the presence of an intact endothelium. This latter
aspect of our study is important because Jennings et al. (2004)
described how nitrergic nerves in the dorsal aorta and intestinal vein
of the Australian short-finned eel (Anguilla australis) provide NO-
mediated vasodilation through nNOS, not eNOS, and we cannot
exclude the possibility that some nitrergic axons were left intact
after the vessel’s dissection. Clearly, the results of this study using
isolated trout coronary microvessels strongly support the hypothesis
of Andreakis et al. (2011), and further experiments should be
conducted to clarify the mechanism(s) (genes/proteins) through
which NO regulates signaling between the endothelium and
vascular smooth muscle in fishes.
The dilatory effect of A23187 on trout coronary microvessels was
also abolished after blockade with the COX inhibitor INDO
(Fig. 4B). While this result is in agreement with previous studies,
which established a role for PGs in A23187-mediated vasodilation
in fish vessels (Olson and Villa, 1991; Park et al., 2000; Jennings
et al., 2004), it raises an interesting point. If INDO specifically
blocks PG-related pathways and L-NIO specifically blocks the
production of NO, then why did blocking only one of these two
pathways still result in the complete elimination of a vasodilator
response? Indeed, our results suggest that both PG and NO
signaling cascades may be required to achieve dilation of trout
coronary microvessels with A23187. The existence of a ‘cross-talk’
(i.e. interaction) between NO and PG pathways has been speculated
many times based on studies on mammalian cells (Salvemini
et al., 1993; Vassalle et al., 2003; Mollace et al., 2005). In fact,
Salvemini et al. (1993) showed that inhibition of endogenous NO
release by NOS inhibitors markedly attenuated the release of
prostaglandin E2 (PGE2). If a similar relationship exists between
the NO and PG pathways in the trout coronary microvasculature,
it is possible that the blockade of either pathway is sufficient
to allow the A23187 endothelium-dependent vasodilation to be
overridden by the simultaneous release of an endothelium-
dependent constriction factor; possibly explaining the endothelium-
dependent vasoconstriction observed in Fig. 4.
Endothelium-dependent vasoconstriction responses to A23187
have been previously reported in mammals. Lüscher et al. (1992)
demonstrated that the calcium ionophore A23187 is capable of
stimulating the release of endothelin-1 by endothelial cells in certain
blood vessels and A23187 (at 10−7 to 10−6 mol l−1) was shown by
Shi et al. (2007) to cause an endothelium-dependent contraction of rat
femoral arteries that was abolished by INDO, suggesting the release
of a COX-dependent constriction factor. In trout, endothelin-1
induces a powerful concentration-dependent constriction of isolated
coronary vessels (maximum dilation, ∼80% at 10−7 mol l−1) (Costa
et al., 2015) and thus this vasoactive agent could potentially be
involved in the A23187-induced constriction observed in this study.
In conclusion, this is the first study to demonstrate a functional
link between the immune and cardiovascular systems in fishes.
Administration of the pro-inflammatory cytokine rIL-1β dilated
isolated coronary microvessels of steelhead trout in a concentration-
dependent manner (maximum dilation, 31% at 10−7 mol l−1): an
effect that was not influenced by incubation at high temperature
(20°C), but was at least partially mediated by PG. We also present
data suggesting that both endothelium-derived NO and
prostaglandins are required for A23187-mediated vasodilation of
trout coronary arterioles (fish vessels), and that this vasodilation
normally overshadows the slight (5–15%) constriction induced
by this agent. These are novel findings that contribute greatly to
the field of fish cardiovascular physiology, and pave the way for
future in vivo and in vitro experiments to examine the role of this
cytokine and other factors in controlling blood flow and pressure in
fish.
MATERIALS AND METHODS
Experimental animals
All procedures followed the guidelines published by the Canadian Council
on Animal Care and were approved by the Institutional Animal Care
Committee from Memorial University of Newfoundland (MUN). Adult
steelhead trout were purchased from a cage-culture site on the south coast of
Newfoundland (Canada) and held in seawater at 10±1.0°C in 6 m3 tanks at
the Dr Joe Brown Aquatic Research Building (JBARB) (Department of
Ocean Sciences, MUN) for a minimum of 5 weeks before experiments
began. Fish were fed a maintenance ration (1.5% body mass−1 every
2 days) of commercial pellets (Skretting, Vancouver, BC, Canada) while
held at the JBARB, and were maintained on a 12 h:12 h light:dark
photoperiod.
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Heart sampling
Fish were killed by a sharp blow to the head, and the heart was quickly
removed and placed in ice-chilled 0.9% NaCl. The bulbus and the atrium
were then removed and the ventricle transferred to a temperature-controlled
dissection dish filled with cooled (4±0.5°C) physiological saline solution.
The ventricle was then cut in half under a dissecting microscope (Model
MZ9s; Leica Microsystems Inc., Concord, ON) to allow dissection of the
arterioles (microvessels). The physiological saline solution contained (in
mmol l−1) 155.0 NaCl, 4.7 KCl, 2.5 CaCl2·2H2O, 1.99 MgSO4·7H2O, 3.0
HEPES acid, 7.0 HEPES sodium salt, 1.0 NaH2PO4·H2O and 5.6 glucose.
This saline, as well as high-KCl and zero-calcium physiological saline
solutions (see below), were buffered to a pH of 7.8 at 10°C and filtered
through a 0.22 µm cellulose acetate, low protein binding membrane
(Corning® 430521, Corning Inc., Corning, NY, USA) prior to use.
Isolation and cannulation of coronary arterioles
The techniques for isolation and cannulation of trout coronary arterioles
have been described previously (Costa et al., 2015). In brief, an unbranched
arteriole of approximately 80–150 µm in external diameter and 1–1.5 mm in
length was selected and carefully dissected free from the surface of the
ventricle. After careful removal of any remaining extraneous tissue, the
arteriole was transferred for cannulation to a custom-made (Technical
Services, MUN) vessel bath (volume 2 ml) containing physiological saline
at the experimental temperature (10°C). This vessel bath is made of titanium
(to resist corrosion and ensure efficient heat transfer) and is equipped with a
water jacket that allows temperature control of the saline solution within the
bath throughout the experiment. The temperature of the physiological saline
within the vessel bath was maintained by connecting the water jacket to a
recirculating water bath (Isotemp Model 3016S, Thermo Fisher Scientific
Inc., Waltham, MA, USA). The vessel chamber was, in turn, attached to a
specially designed stage (Microcirculation Research Institute, Texas A&M
University, College Station, TX, USA) equipped with micromanipulators
(Model MMN-1, Narishige, East Meadow, NY, USA) that housed pipette
holders and allowed for adjustments of pipette positioning in all three
dimensions.
The arteriole was cannulated by pulling one end of the vessel onto the tip
of a glass micropipette filled with physiological saline containing 1%
albumin, and securely tying it to the pipette with 11-0 ophthalmic suture
(Alcon Medical Safety Inc, Fort Worth, TX, USA). Any remaining blood
was then flushed out of the vessel at low perfusion pressure (10 cmH2O or
∼7.5 mmHg), and the other end of the vessel was cannulated using a second
micropipette and tied in place.
After cannulation was complete, the vessel stage was transferred from the
dissecting microscope to an inverted microscope (Model DM1RB, Leica
Microsystems Inc.) with a 20× objective, and coupled to a video camera
(Sony CCD-Iris; Sony Corporation, Japan) and videomicrometer system
(Model VIA-100; Boeckeler Instruments Inc., Tuscon, AZ) for continuous
measurement of the vessel’s internal diameter throughout the experiment.
At this point, the glass pipettes were connected to wall-mounted,
independent, adjustable pressure reservoirs filled with saline solution and
pressure in the vessels was set to 20 cmH2O (∼15 mmHg) luminal pressure,
without flow, by adjusting the height of the reservoirs. This pressure
approximates the intraluminal pressure for trout coronary microvessels of
this size range in vivo; based on: (1) mammalian studies that have estimated
the intraluminal pressure of coronary arterioles in this size range to be
approximately 50% of mean aortic pressure (Chilian et al., 1986; Kuo et al.,
1988); and (2) values for dorsal aortic blood pressure in rainbow trout at rest
that range from 38.8 to 42 cm of H2O (∼28.5 to 31 mmHg) (Olson et al.,
1991; Gamperl et al., 1995; Perry and Reid, 2002). The vessel was then set to
its resting in situ length (as measured with an eyepiece micrometer during
dissection) by stretching the vessel using the pipette micromanipulators, and
tested for leaks (any preparations with leaks were excluded from further
investigation). At this point, the bath solution was replaced with fresh
physiological saline and the vessel allowed approximately 30 min to
develop spontaneous tone. However, vessels that did not regain tone were
pre-contracted by replacing the bath with physiological saline containing
50 mmol l−1 KCl: the exact composition of this saline (in mmol l−1) was
110.0 NaCl, 50.0 KCl, 2.5 CaCl2·2H2O, 1.99 MgSO4·7H2O, 3.0 HEPES
acid, 7.0 HEPES sodium salt, 1.0 NaH2PO4·H2O and 5.6 glucose.
Preliminary experiments showed that this concentration of KCl produced
a constriction of 60–70% of maximum diameter (within 10 min) that could
be maintained for at least 120 min (data not shown). This degree of
constriction was similar to that observed for trout coronary arterioles that
developed spontaneous tone, and is considered in mammalian studies to be
an appropriate level of spontaneous tone for similar-sized arterioles (Kuo
et al., 1988, 1991; Hein and Kuo, 1998).
Recombinant interleukin-1β production and purification
Recombinant rainbow trout IL-1βwas produced using Escherichia coli after
cloning the cDNA encoding the predicted mature IL-1β peptide (Zou et al.,
1999) into the pQE30 expression vector (Invitrogen, Carlsbad, CA, USA)
(Hong et al., 2001). The recombinant protein was then purified using Ni-
nitroloacetic acid metal affinity chromatography, checked for size and purity
by SDS-PAGE and resuspended in buffer containing 20 mmol l−1 Tris-HCl
(pH 8.0), 100 mmol l−1 NaCl, 100 mmol l−1 KCl, 5 mmol l−1 MgCl2,
5 mmol l−1 β-mercaptoethanol, 20% glycerol, 0.1% NP-40 (nonyl
phenoxypolyethoxylethanol), 250 mmol l−1 imidazole. After storage at
−80°C, the recombinant protein was further purified by passing it through a
Detoxi-Gel endotoxin removing column (Thermo Scientific, Waltham,MA,
USA), and size and purity verified again by SDS-PAGE (Ready Gels
10–20% Tris-HCl, Bio-Rad Laboratories Inc., Hercules, CA, USA). The
final concentration of rIL-1β (mg ml−1) was determined by optical
densitometry using the Bradford colorimetric method [Thermo Scientific
Coomassie (Bradford) Protein Assay Kit 23200, Thermo Scientific,
Waltham, MA, USA] and BSA (bovine serum albumin) as a standard.
Vasoactivity of recombinant interleukin-1β
Preliminary studies
Before testing the vasoactivity of rIL-1β in trout isolated coronary
microvessels (i.e. performing concentration–response curves) a number
of preliminary trials were performed to assess the vasoactivity of the buffer
(i.e. vehicle) in which the protein was stored. The original buffer showed an
extremely strong vasodilator effect (40–50% from resting ID), probably
because of two components meant to maintain protein stability (i.e.
imidazole and β-mercaptoethanol) (data not shown). Thus, a buffer
exchange with a suitable, non-vasoactive protein stabilizer was necessary.
The rIL-1β was subsequently dialyzed into microvessel saline solution (see
above) containing 0.2 mmol l−1 dithiothreitol (DTT), for protein stability;
this concentration of DTT showed very low vasoactivity (see Fig. 1).
Dialysis was performed overnight at approximately 4–6°C using 10 mm
Spectra/Por dialysis tubing (12,000–14,000 molecular mass cut off;
Spectrum Laboratories Inc., Rancho Dominguez, CA, USA), and the
concentration of rIL-1β was determined following the buffer exchange
(i.e. post-dialysis) using the Bradford method. The rIL-1β in microvessel
saline with 0.2 mmol l−1 DTT was then aliquoted into appropriate volumes
(i.e. based on protein concentration post-dialysis) and kept at −80°C prior
to use.
The effect of temperature
The concentration-dependent effect of rIL-1β on vessel vasoactivity was
assessed by exposing vessels to increasing concentrations of rIL-1β (10−12
to 10−7 mol l−1) at 10 and 20°C, and measuring changes in the vessel’s ID.
To perform this experiment, we dissected two separate vessels from each
ventricle, and randomized the order of test temperatures (10 vs 20°C) to
ensure that the results were not affected by the post-dissection period.
Briefly, a vessel was dissected free and cannulated as described above. After
approximately 20 min, the vessel bath temperature was not changed (10°C)
or was increased to 20°C over a period of 1 h by adjusting the temperature of
the recirculating bath connected to the water jacket of the vessel bath (see
above). After this 1 h period, the bath solution was replaced with fresh saline
at the appropriate temperature, and the vessel was then allowed
approximately 20 min to develop spontaneous tone. Vessels that did not
regain tone were pre-contracted by replacing the saline in the bath with
saline containing 50 mmol l−1 KCl.
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Recombinant IL-1βwas sequentially injected into the vessel bath in order
to achieve the desired final concentration, with the volume injected (20–
300 µl) varying depending on rIL-1β concentration after dialysis. Changes
in the vessel’s ID were measured 10 min after injection, and the next amount
added to the bath immediately thereafter. The range of rIL-1β concentrations
chosen for this study was based on previous mammalian and trout rIL-1β
studies (Lin et al., 1997; Hong et al., 2001, 2003; Peddie et al., 2001). The
highest concentration used was equivalent to the IL-1β dosage that induced
heat-stroke-like cardiovascular symptoms in the rat (Lin et al., 1997), after
taking into consideration trout blood volume (∼35 ml kg−1) (Kiceniuk and
Jones, 1977; Olson, 2011).
Once the final measurement was complete on vessels at 10 or 20°C, the
vessel was washed three times with physiological saline. The saline in the
bath was then replaced with physiological saline without calcium (i.e.
0 mmol l−1 vs the normal 2.5 mmol l−1), and a single extraluminal injection
of adenosine (final bath concentration 10−4 mol l−1) was given in order to
obtain the vessel’s maximum diameter. Adenosine was used because of its
very strong vasodilator effect on trout coronary arterioles (Costa et al.,
2015). The time required to obtain the vessel’s maximum diameter was
approximately 30 min. The zero-calcium physiological saline consisted of
(in mmol l−1) 155.0 NaCl, 4.7 KCl, 1.99 MgSO4·7H2O, 3.0 HEPES acid,
7.0 HEPES sodium salt, 1.0 NaH2PO4·H2O and 5.6 glucose.
In order to assess whether any change in vessel responsiveness was due to
the acute increase in temperature, a preliminary series of injections with
increasing concentrations (10−9 to 10−4 mol l−1) of adenosine were made in
vessels acutely warmed (present study, N=3), and compared with the
response of vessels at 10°C (Costa et al., 2015). Similar to the trout’s isolated
coronary microvessels at 10°C, vessels at 20°C showed a very clear
concentration-dependent vasodilation in response to adenosine; the
maximum vasodilation was approximately 70% from resting ID compared
with 60% at 10°C (data not shown).
Role of the endothelium, NO and prostaglandins in rIL-1β-induced dilation
Vessel denudation
In order to examine the role of the endothelium, and of potential
endothelium-derived relaxation factors (i.e. NO and PGs) in rIL-1β-
induced vasodilation, we needed to remove (denude) the endothelial cell
layer of some coronary arterioles while leaving the vascular smooth muscle
intact and functional. There are a number of studies where physical
denudation of the vascular endothelium of fish vessels has been performed
(Farrell and Johansen, 1995; Miller and Vanhoutte, 2000; Park et al., 2000).
However, the vessels used in the latter studies were considerably larger than
the ones used in the present research (80–150 µm external diameter), and
the use of physical methods proved impossible. Thus, we decided on a
chemical denudation approach that has been successfully used in
mammalian microvascular studies (Ishizaka and Kuo, 1996; Gamperl
et al., 2002).
Removal of the endothelial cells was achieved using the non-ionic
detergent, 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate
(CHAPS). Briefly, after setting the vessel to its in situ length and resting
intraluminal pressure (see above), the valves connecting the micropipettes to
the pressure reservoirs were closed. This allowed for access to the inside of
the micropipette (through the opposite side of the pipette holder) and for the
injection of 0.3 ml of CHAPS (0.4%) using P10 tubing (Intramedic Clay
Adams, Becton Dickson) inserted as close as possible to the tip of the
pipette. After 2 min of exposure to CHAPS, the vessel was carefully re-
pressurized and a height differential of 4 cm of H2O between the two
pressure reservoirs was used for 2 min to flush the CHAPS solution out of
the vessels. After this ‘washing-out’ period, the pressure was equalized by
bringing both pressure reservoirs back to 20 cm of H2O (∼15 mmHg) and
the preparation set to no-flow conditions by closing the valve on the side that
the CHAPS solution was injected.
The success of this method of denudation was evaluated by: (1)
examining microvessel morphology/structure before and after denudation
using transmission electron microscopy (TEM) (see below and Fig. 2A,B);
and (2) exposing vessels to increasing concentrations of the endothelium-
dependent calcium ionophore A23187, which causes a concentration-
dependent relaxation of teleost blood vessels (Olson and Villa, 1991; Park
et al., 2000; Jennings et al., 2004) and measuring changes in the vessel’s ID
at 10 min post-injection before and after denudation (Fig. 2C). To ensure
that vascular smooth muscle function was not compromised by CHAPS
treatment, the vessel’s response to a single concentration of SNP
(10−4 mol l−1) was also examined following the series of A23187
injections (10−9 to 10−4 mol l−1) (Fig. 2C).
Role of the endothelium
To examine the role of the vascular endothelium in the vasoactivity of rIL-
1β, vessels were exposed to increasing concentrations of rIL-1β (10−12 to
10−7 mol l−1) before and after endothelial denudation. The physiological
saline in the vessel bath was exchanged three times to remove any residual
amounts of rIL-1β from the previous injection series (before CHAPS
exposure) and the vessels were allowed up to 20 min to return to their initial
resting diameter after denudation before the second series of rIL-1β
injections was performed. Once the final measurement was complete (post-
denudation), the vessels were again washed and pre-constricted with
50 mmol l−1 KCl. Then, a single injection of SNP (10−4 mol l−1) was made
in order to ensure that smooth muscle vasodilator function was intact. Only
vessels responsive (i.e. vasodilation) to SNP were included in the study.
Finally, the vessels were washed three times with physiological saline, then
the saline in the bath was replaced with physiological saline without calcium
and a single injection of adenosine (10−4 mol l−1) performed to obtain the
vessel’s maximum diameter (see above).
Role of NO and prostaglandins
To elucidate the role of the endothelium-derived vasodilators NO and PGs in
rIL-1β induced vasodilation, trout coronary microvessels were pre-incubated
with the non-selective NO synthase inhibitor N5-(1-iminoethyl)-L-ornithine,
dihydrochloride (L-NIO, 10−4 mol l−1) or the non-selective cyclooxygenase
(COX) inhibitor indomethacin (INDO, 10−4 mol l−1) before being exposed to
increasing concentrations of rIL-1β (see above). These experiments were first
performed on intact vessels, and again on the same vessels after the
endothelium had been removed using CHAPS. At the end of each isolated
vessel trial, a single injection of SNP (10−4 mol l−1) was used to ensure that the
vasodilator capacity of the smoothmusclewas intact following denudation. All
drugs were administered extraluminally and vessels incubated with each
antagonist (i.e. L-NIO or INDO) for at least 30 min before exposure to rIL-1β.
Role of NO and prostaglandins in calcium ionophore A23187-
induced dilation
To elucidate the role of NO and PGs in vasodilation induced by the
endothelium-derived calcium ionophore A23187, microvessels were pre-
incubated with L-NIO (10−4 mol l−1) or INDO (10−4 mol l−1) and then
exposed to increasing concentrations of A23187 (see above). These
experiments were first performed on intact vessels, and again on the same
vessels after the endothelium had been removed using CHAPS (0.4%). At
the end of each isolated vessel trial, a single injection of SNP (10−4 mol l−1)
was used to ensure that the vasodilator capacity of the smooth muscle was
intact following denudation. Only vessels responsive (i.e. vasodilation) to
SNP were included in the study. All drugs were administered extraluminally
and vessels incubated with each antagonist (i.e. L-NIO and INDO) for at
least 30 min before exposure to A23187.
Vasoactive agents and chemicals
The purinergic receptor agonist adenosine, the NO donor SNP, the
endothelium-dependent vasodilator calcium ionophore A23187 and the
non-ionic detergent CHAPS were all purchased from Sigma-Aldrich
(Oakville, ON, Canada), whereas INDO and L-NIO were purchased from
Cedarlane Corp. (Burlington, ON, Canada). All solutions were made fresh
and kept on ice until needed. Adenosine and SNP were dissolved in the
physiological saline solution, whereas A23187, INDO and L-NIO were
dissolved in 99% ethanol. Note that a series of preliminary (sham) injections
(with ethanol dissolved in saline at appropriate concentrations) was performed
to ensure that the vehicle had novasoactivity. These injections did not result in
any measureable (i.e. ≤0.5%) changes in vessel ID (data not shown).
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Transmission electron microscopy
Vessels used for TEM images were subjected to a similar protocol as vessels
used in other parts of the study with the exception of exposure to A23187 or
SNP. Vessels segments were then placed in Karnovsky fixative for 24 h and
stored in 0.1 mol l−1 Na cacodylate buffer until processed. Vessels were
osmicated and then dehydrated, using graded alcohol and acetone, followed
by infiltration with EPON resin, embedded in embedding molds and
polymerized overnight at 80°C. Blocks were initially trimmed and 0.5 µm
sections cut on a Reichert ultra-cut S microtome. Sections were stained
using toluidine blue and examine under a light microscope for correct
orientation and depth for cutting ultra-thin sections. Thin sections were cut
at 85 nm (mounted on a 300 mesh copper grid) and stained with uranyl
acetate followed by lead citrate stain before image capture.
Data analysis
All measurements of vessel ID were normalized to the resting ID at
20 cmH2O luminal pressure (i.e. after vessels developed basal tone or were
pre-constricted with 50 mmol l−1 KCl). Repeated-measures (RM) two-way
ANOVAs, followed by Tukey’s post hoc tests, were used to examine the
effects of rIL-1β or A23187 concentration on microvessel ID under a
number of conditions: (1) 10 vs 20°C (rIL-1β only); (2) intact versus
denuded vessels; (3) and L-NIO or INDO alone, or in combination, with
denudation.When the interaction between the two explanatory variables in a
particular analysis was significant, separate RM one-way ANOVAs were
used to test for differences in vessel ID within a treatment due to rIL-1β or
A23187 concentration, while t-tests were used to identify differences in the
effects of each treatment at a particular concentration of rIL-1β or A23187.
A t-test was also used to test for smooth muscle reactivity in denuded vessels
(endothelium removed) by comparing the vessel’s ID after the last injection
of either rIL-1β (10−7 mol l−1) or A23187 (10−4 mol l−1) and SNP (10−4
mol l−1).
All statistical analyses were performed using Sigma Plot 12.0 (Systat
Software Inc. San Jose, CA) with P<0.05 as the level of statistical
significance. All values presented in the text, tables and figures are
expressed as means±1 s.e.m.
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Procaccini, G., Sordino, P. and Palumbo, A. (2011). Evolution of the nitric oxide
synthase family in metazoans. Mol. Biol. Evol. 28, 163-179.
Bataillard, A. and Sassard, J. (1994). Cardiovascular effects of human
recombinant interleukin-1β in conscious rats. Am. J. Physiol. Regul. Integr.
Comp. Physiol. 266, R1148-R1153.
Beasley, D. and McGuiggin, M. E. (1995). Interleukin 1 induces prostacyclin-
dependent increases in cyclic AMP production and does not affect cyclic GMP
production in human vascular smooth muscle cells. Cytokine 7, 417-426.
Berne, R. M. and Levy, M. N. (1997). Cardiovascular Physiology, 7th edn.
pp. 171–194. Michigan: Mosby-Year Book Inc.
Buonocore, F., Forlenza, M., Randelli, E., Benedetti, S., Bossù, P., Meloni, S.,
Secombes, C. J., Mazzini, M. and Scapigliati, G. (2005). Biological activity of
sea bass Dicentrarchus labrax L. recombinant interleukin-1b. Mar. Biotechnol. 7,
609-617.
Chilian,W.M., Eastham, C. L. andMarcus,M. L. (1986). Microvascular distribution
of coronary vascular resistance in beating left ventricle. Am. J. Physiol. Heart Circ.
Physiol. 251, H779-H788.
Chiu, W.-T., Kao, T.-Y. and Lin, M.-T. (1995). Interleukin-1 receptor antagonist
increases survival in rat heatstroke by reducing hypothalamic serotonin release.
Neurosci. Lett. 202, 33-36.
Combes, A., Frye, C. S., Lemster, B. H., Brooks, S. S., Watkins, S. C., Feldman,
A. M. and McTiernan, C. F. (2002). Chronic exposure to interleukin 1β induces a
delayed and reversible alteration in excitation-contraction coupling of cultured
cardiomyocytes. Pflugers Arch. 445, 246-256.
Costa, I. A. S. F., Hein, T. W. and Gamperl, A. K. (2015). Cold-acclimation leads to
differential regulation of the steelhead trout (Oncorhynchus mykiss)
coronary microcirculation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 308,
R743-R754.
Dinarello, C. A. (1997). Interleukin-1. Cytokine Growth Factor Rev. 8, 253-265.
Duling, B. R., Gore, R. W., Dacey, R. G., Jr and Damon, D. N. (1981). Methods for
isolation canulation and in vitro study of single microvessels. Am. J. Physiol. Heart
Circ. Physiol. 241, H108-H116.
Duncan, D. J., Yang, Z., Hopkins, P. M., Steele, D. S. and Harrison, S. M. (2010).
TNF-α and IL-1β increase Ca2+ leak from the sarcoplasmic reticulum
and susceptibility to arrhythmia in rat ventricular myocytes. Cell Calcium 47,
378-386.
Fago, A., Jensen, F. B., Tota, B., Feelisch,M., Olson, K. R., Helbo, S., Lefevre, S.,
Mancardi, D., Palumbo, A., Sandvik, G. K. et al. (2012). Integrating nitric
oxide, nitrite and hydrogen sulfide signaling in the physiological adaptations to
hypoxia: a comparative approach.Comp. Biochem. Physiol. A Mol. Integr. Physiol.
162, 1-6.
Farrell, A. P. (2009). Environment, antecedents and climate change: lessons from
the study of temperature physiology and river migration of salmonids. J. Exp. Biol.
212, 3771-3780.
Farrell, A. P. and Johansen, J. A. (1995). Vasoactivity of the coronary artery of
rainbow trout, steelhead trout, and dogfish: lack of support for non-prostanoid
endothelium-derived relaxation factors. Can. J. Zool. 73, 1899-1911.
Farrell, A. P., Gamperl, A. K., Hicks, J. M. T., Shiels, H. A. and Jain, K. E. (1996).
Maximum cardiac performance of rainbow trout (Oncorhynchus mykiss) at
temperatures approaching their upper lethal limit. J. Exp. Biol. 199, 663-672.
Farrell, A. P., Eliason, E. J., Sandblom, E. and Clark, T. D. (2009). Fish
cardiorespiratory physiology in an era of climate change. Can. J. Zool. 87,
835-851.
Fritsche, R., Schwerte, T. and Pelster, B. (2000). Nitric oxide and vascular
reactivity in developing zebrafish Danio rerio. Am. J. Physiol. Regul. Integr. Comp.
Physiol. 279, R2200-R2207.
Gamperl, A. K., Axelsson, M. and Farrell, A. P. (1995). Effects of swimming and
environmental hypoxia on coronary blood flow in rainbow trout. Am. J. Physiol.
Regul. Integr. Comp. Physiol. 269, R1258-R1266.
Gamperl, A. K., Hein, T. W., Kuo, L. and Cason, B. A. (2002). Isoflurane-induced
dilation of porcine coronary microvessels is endothelium dependent and inhibited
by glibenclamide. Anesthesiology 96, 1465-1471.
Gamperl, A. K., Swafford, B. L. and Rodnick, K. J. (2011). Elevated temperature,
per se, does not limit the ability of rainbow trout to increase stroke volume.
J. Thermal. Biol. 36, 7-14.
Gollock, M. J., Currie, S., Petersen, L. H. and Gamperl, A. K. (2006).
Cardiovascular and haematological responses of Atlantic cod (Gadus morhua)
to acute temperature increase. J. Exp. Biol. 209, 2961-2970.
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